Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response-Reference-Cited by-同舟云学术

Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response

Published:2019-11 Issue: Volume:143 Page:101-114
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Shearn Colin T.,Fennimore Blair,Orlicky David J.,Gao Yue R.,Saba Laura M.,Battista Kayla D.,Aivazidis Stefanos,Assiri Mohammed,Harris Peter S.,Michel Cole,Merrill Gary F.,Schmidt Edward E.,Colgan Sean P.,Petersen Dennis R.

Funder

PSC

PBC

National Institutes of Health Institute of Alcohol Abuse and Alcoholism

Gastrointestinal and Liver Innate Immunity Program (GALIIP

University of Colorado Denver Anschutz Medical Campus

NIH

NCRR

CTSI

University of Colorado Cancer Center

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference79 articles.

1. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review;Boonstra;J. Hepatol.,2012

2. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis;Molodecky;Hepatology,2011

3. Will we ever model PSC? - "it's hard to be a PSC model!;Pollheimer;Clin Res Hepatol Gastroenterol,2011

4. Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage;Vendemiale;J. Hepatol.,2002

5. Pathogenic role of oxidative and nitrosative stress in primary biliary cirrhosis;Grattagliano;World J. Gastroenterol.,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of Nrf2/HO-1 signaling pathway exacerbates cholestatic liver injury;Communications Biology;2024-05-23

2. MRI Probes for In Vivo Aldehyde Sensing;Analysis & Sensing;2024-05-16

3. Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition;PLOS ONE;2023-08-30

4. Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies;Frontiers in Pharmacology;2023-06-15

5. Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury;Hepatology Communications;2023-01